Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $672.12 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $178.69 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $112.09 | 5 | $0 (2024) |
| PFIZER INC. | $85.55 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $59.06 | 3 | $0 (2021) |
| Novo Nordisk Inc | $58.69 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $39.33 | 2 | $0 (2024) |
| Lilly USA, LLC | $36.39 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $30.49 | 1 | $0 (2024) |
| ATRICURE, INC. | $26.58 | 1 | $0 (2023) |
| Amgen Inc. | $24.64 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $363.45 | 17 | AstraZeneca Pharmaceuticals LP ($88.36) |
| 2023 | $221.68 | 4 | Abbott Laboratories ($150.76) |
| 2021 | $86.99 | 4 | Amarin Pharma Inc. ($59.06) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: VACCINES | ||||||
| 05/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 04/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/19/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Cardiology | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/13/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Diabetes | ||||||
| 01/29/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.71 | General |
| 01/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $150.76 | General |
| Category: Vascular | ||||||
| 08/14/2023 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Endocrinology | ||||||
| 05/03/2023 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/10/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Heart Failure | ||||||
| 04/27/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardiovascular | ||||||
| 02/23/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Cardiovascular | ||||||
| 01/26/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 483 | 555 | $124,088 | $28,657 |
| 2022 | 5 | 457 | 558 | $126,284 | $34,789 |
| 2021 | 5 | 424 | 479 | $70,752 | $23,191 |
| 2020 | 5 | 252 | 286 | $44,471 | $11,848 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 170 | $52,141 | $9,873 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 87 | 91 | $12,433 | $5,903 | 47.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 73 | 109 | $21,827 | $5,846 | 26.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 26 | $7,513 | $2,097 | 27.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 21 | $7,998 | $1,851 | 23.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $7,800 | $1,570 | 20.1% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 108 | 108 | $12,088 | $1,481 | 12.3% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 15 | 16 | $2,288 | $36.68 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 250 | $91,178 | $20,963 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 148 | 172 | $17,590 | $10,907 | 62.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 28 | 30 | $5,870 | $1,456 | 24.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 56 | 56 | $6,044 | $761.16 | 12.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 15 | 15 | $765.00 | $535.39 | 70.0% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 31 | 35 | $4,837 | $166.09 | 3.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 102 | $23,016 | $8,489 | 36.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 83 | 101 | $10,797 | $6,939 | 64.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 54 | 67 | $11,622 | $3,348 | 28.8% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 180 | 180 | $19,260 | $2,676 | 13.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 13 | $3,270 | $933.40 | 28.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 16 | 16 | $2,787 | $805.60 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 70 | 96 | $16,219 | $4,914 | 30.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 40 | $8,920 | $2,822 | 31.6% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 94 | 95 | $9,857 | $1,465 | 14.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 25 | 26 | $3,295 | $1,106 | 33.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $4,452 | $1,069 | 24.0% |
About Cheri Hayes, APRN
Cheri Hayes, APRN is a Nurse Practitioner healthcare provider based in Manchester, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497727085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cheri Hayes, APRN has received a total of $672.12 in payments from pharmaceutical and medical device companies, with $363.45 received in 2024. These payments were reported across 25 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($672.12).
As a Medicare-enrolled provider, Hayes has provided services to 1,616 Medicare beneficiaries, totaling 1,878 services with total Medicare billing of $98,484. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Adult Health, Adult Health
- Location Manchester, NH
- Active Since 02/07/2006
- Last Updated 11/02/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1497727085
Products in Payments
- MITRACLIP (Device) $150.76
- FARXIGA (Drug) $112.09
- Vascepa (Drug) $59.06
- ELIQUIS (Drug) $42.29
- Ozempic (Drug) $40.00
- LEQVIO (Drug) $39.33
- EVKEEZA (Biological) $30.49
- VYNDAQEL (Drug) $28.84
- CardioMEMS HF System (Device) $27.93
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $26.58
- Repatha (Biological) $24.64
- MOUNJARO (Drug) $20.68
- t:slim X2 Insulin Pump with Control-IQ (Device) $20.61
- Rybelsus (Drug) $18.69
- PREVNAR 20 (Biological) $14.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Manchester
Megan Carlucci, Aprn, APRN
Nurse Practitioner — Payments: $19,930
Scott Chastek, Crna / Arnp, CRNA / ARNP
Nurse Practitioner — Payments: $1,960
Paul Arnstein, Arnp, ARNP
Nurse Practitioner — Payments: $1,710
Victoria Schmelzer
Nurse Practitioner — Payments: $1,597
Heidi Odum, Aprn, APRN
Nurse Practitioner — Payments: $1,518
Mrs. Candice Kusch, Np, NP
Nurse Practitioner — Payments: $1,419